1-20 of 28
Roland Bassett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Efficacy of the PARP Inhibitor Olaparib Combined with High-Dose Chemotherapy and Autologous Stem-Cell Transplant for Refractory Lymphomas

Yago Nieto, Benigno C Valdez, Peter F Thall, Jeremy L. Ramdial, Samer A Srour, Chitra Hosing, Neeraj Saini, Amin M Alousi, Muzaffar H Qazilbash, Uday R Popat, Alison Gulbis, Terri Lynn Shigle, Roland Bassett, Maria Guillermo-Pacheco, Celina Ledesma, Paolo Strati, Sairah Ahmed, Raphael Steiner, Jason Westin, Ranjit Nair, Swaminathan P. Iyer, Richard E Champlin, Elizabeth J Shpall, Borje S Andersson
Journal: Blood
Blood (2022) 140 (Supplement 1): 1183–1184.
https://doi.org/10.1182/blood-2022-156121
Published: 2022
Journal Articles

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Yago Nieto, Pinaki P Banerjee, Indreshpal Kaur, Lori Griffin, Christina Ganesh, Lucila Kerbauy, Rafet Basar, Mecit Kaplan, Sanjida Islam, Daniel Esqueda, Roland Bassett, Melissa Timmons, Jeremy L. Ramdial, Samer A Srour, Neeraj Saini, Chitra Hosing, Sairah Ahmed, Swaminathan Padmanabhan Iyer, Karenza Alexis, Michael Emig, Andreas Harstrick, Elizabeth J Shpall, Katy Rezvani
Journal: Blood
Blood (2022) 140 (Supplement 1): 415–416.
https://doi.org/10.1182/blood-2022-156125
Published: 2022
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial

Uday R. Popat, Roland Bassett, Peter F. Thall, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Naval Daver, Farhad Ravandi, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson, Rohtesh S. Mehta
Journal: Blood
Blood (2021) 138 (Supplement 1): 556.
https://doi.org/10.1182/blood-2021-152450
Published: 2021
Journal Articles

Optimizing Myeloablative Fractionated Busulfan, Fludarabine and Thiotepa Regimen: Results of Two Parallel Cohorts in a Phase 2 Prospective Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Katayoun Rezvani, Muzaffar H. Qazilbash, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1802.
https://doi.org/10.1182/blood-2021-146655
Published: 2021
Journal Articles

Post-Transplant Cyclophosphamide Versus Tacrolimus and Methotrexate to Prevent Graft-Versus-Host Disease in Recipients of Matched Donor Transplantation: Comparison of Sequential Cohorts in a Prospective Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Hagop Kantarjian, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1803.
https://doi.org/10.1182/blood-2021-146245
Published: 2021
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Venetoclax in Patients with AML/MDS: Prospective Phase II Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Alison Gulbis, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Marina Konopleva, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2879.
https://doi.org/10.1182/blood-2021-146253
Published: 2021
Journal Articles

Minimal Residual Disease Eradication with Guadecitabine (SGI-110) in the Post-Transplant Setting

Betul Oran, MDMS, Amin M. Alousi, MD, Rohtesh S. Mehta, MDMPH,MS, David Marin, Partow Kebriaei, MD, Uday R. Popat, MD, Amanda L. Olson, Jessica M McCarty, RN, Jennifer D Ramos, RN, Roland Bassett, Harold N. Keer, MDPhD, Peter F Thall, PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-134204
Published: 2020
Journal Articles

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Rohtesh S. Mehta, MDMPH,MS, Roland Bassett, Julianne Chen, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Amin M. Alousi, MD, Gheath Alatrash, Qaiser Bashir, MD, Stefan Ciurea, MD, Chitra Hosing, MD, Jin S. Im, Partow Kebriaei, MD, Amanda L. Olson, Betul Oran, MDMS, Muzaffar H. Qazilbash, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Borje S. Andersson, MD, PhD, Richard E. Champlin, MD, Uday R. Popat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-139325
Published: 2020
Journal Articles

Improved Outcomes for Patients Receiving High-Doses of IL-21 Ex Vivo Expanded NK Cells after Haploidentical Transplantation (haploSCT): Long-Term Follow-up of a Phase 1/2 Clinical Trial with Comparison to CIBMTR Controls

Stefan O. Ciurea, MD, Roland Bassett, Doris Soebbing, Gabriela Rondon, MD, Kai Cao, MS, MD, Amanda L. Olson, MD, Qaiser Bashir, MBBS, Elizabeth J. Shpall, MD, Steven Devine, Marcelo C. Pasquini, MD, Andrew St. Martin, MS, Dean Anthony Lee, MD PhD, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 700.
https://doi.org/10.1182/blood-2019-123936
Published: 2019
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study

Uday Popat, MD, Rohtesh S. Mehta, MD, Roland Bassett, Amanda L. Olson, MD, Julianne Chen, Christina Ganesh, BSN, RN, Amin M. Alousi, MD, Paolo Anderlini, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, Chitra Hosing, MD, Jin S Im, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, MD, David Marin, MD, Yago Nieto, MD PhD, Betul Oran, MDMS, Neeraj Saini, MD, Samer Srour, Katayoun Rezvani, MD PhD, Muzaffar Qazilbash, Jeffrey J. Molldrem, Elizabeth J. Shpall, MD, Borje S Andersson, MD PhD, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 256.
https://doi.org/10.1182/blood-2019-122124
Published: 2019
Journal Articles

Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation

Clinical Trials & Observations
Stefan O. Ciurea, Jolie R. Schafer, Roland Bassett, Cecele J. Denman, Kai Cao, Dana Willis, Gabriela Rondon, Julianne Chen, Doris Soebbing, Indreshpal Kaur, Alison Gulbis, Sairah Ahmed, Katayoun Rezvani, Elizabeth J. Shpall, Dean A. Lee, Richard E. Champlin
Journal: Blood
Blood (2017) 130 (16): 1857–1868.
https://doi.org/10.1182/blood-2017-05-785659
Published: 2017
Includes: Supplemental data
Journal Articles

Comparison of Two Apheresis Instruments (Old vs. New) for Granulocyte Collection: A Single Institutional Experience

Fleur M Aung, MD, Roland Bassett, Benjamin Lichtiger, MD PhD, Emil J. Freireich, MD
Journal: Blood
Blood (2016) 128 (22): 5036.
https://doi.org/10.1182/blood.V128.22.5036.5036
Published: 2016
Journal Articles

Most Closely HLA-Matched Third Party Allogeneic CMV Specific T-Cells Generated Using the Cytokine Capture System for the Treatment of CMV Infections after Allogeneic Stem Cell Transplantation

Betul Oran, MD, Muharrem Muftuoglu, MD, Indreshpal Kaur, PhD, Li Li, MD, Eric Yvon, PhD, Glorette Abueg, Roland Bassett, MS, Peter F Thall, PhD, David Marin, MD, Amin M. Alousi, MD, Sairah Ahmed, MD, Stefan O. Ciurea, MD, Shah Nina, MD, Chitra Hosing, MD, Amanda L. Olson, MD, Simrit Parmar, MD, Roy Jones, MD PhD, Uday R. Popat, MD, Borje S. Andersson, MD PhD, Richard E. Champlin, MD, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 4547.
https://doi.org/10.1182/blood.V128.22.4547.4547
Published: 2016
Journal Articles

Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM

Yago Nieto, MD, PhD, Roland Bassett, MS, Paolo Anderlini, MD, Chitra M. Hosing, MD, Amin M. Alousi, MD, Uday R. Popat, MD, Borje S. Andersson, MD PhD, Benigno C. Valdez, PhD, Elizabeth J. Shpall, MD, Sairah Ahmed, MD, Muzaffar Qazilbash, MD, Maria Guillermo, Yasuhiro Oki, MD, Michelle A. Fanale, Fredrick B. Hagemeister, MD, Bouthaina S. Dabaja, MD, Chelsea C Pinnix, MDPhD, Sarah A Milgrom, MD, Priti Tewari, MD, Richard E. Champlin, MD, Roy Jones, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1980.
https://doi.org/10.1182/blood.V126.23.1980.1980
Published: 2015
Journal Articles

A Bayesian, Phase II Randomized Trial of Extracorporeal Photopheresis (ECP) Plus Steroids Versus Steroids-Alone in Patients with Newly Diagnosed Acute Graft Vs. Host Disease (GVHD): The Addition of ECP Improves Gvhd Response and the Ability to Taper Steroids

Amin M. Alousi, MD, Roland Bassett, MS, Julianne Chen, Bethany J Overman, BSN, Chitra M. Hosing, MD, Uday R. Popat, MD, Elizabeth J. Shpall, MD, Yago Nieto, MD PhD, Muzaffar H. Qazilbash, MD, Issa F. Khouri, Partow Kebriaei, MD, Sairah Ahmed, MD, Nina Shah, MD, Katayoun Rezvani, MD, PhD, Kayo Kondo, PhD, Stefan O. Ciurea, MD, Sharon R Hymes, MD, Joyce L Neumann, APN, PhD, Jeffrey J. Molldrem, MD, Tamera R Plair, PA, Richard E. Champlin, MD
Journal: Blood
Blood (2015) 126 (23): 854.
https://doi.org/10.1182/blood.V126.23.854.854
Published: 2015
Journal Articles

Myeloablative Timed Sequential Busulfan Is Safe in Older Patients

Uday R. Popat, MD, Patricia S Fox, MS, Roland Bassett, Julianne Chen, Benigno C. Valdez, PhD, Jitesh Kawedia, Sairah Ahmed, MD, Amin M. Alousi, MD, Qaiser Bashir, Stefan O. Ciurea, MD, Chitra M. Hosing, Roy Jones, Partow Kebriaei, Issa F. Khouri, MD, Yago Nieto, Amanda Olson, Betul Oran, MD, Simrit Parmar, Muzaffar H. Qazilbash, MD, Nina Shah, Elizabeth J Shpall, MD, Borje S Andersson, MD PhD, Richard E. Champlin
Journal: Blood
Blood (2014) 124 (21): 3859.
https://doi.org/10.1182/blood.V124.21.3859.3859
Published: 2014
Journal Articles

Central Nervous System Relapse In Adults With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Amir Hamdi, MD, Raya Mawad, MD, Antonio Di Stasi, MD, Roland Bassett, MS, Roberto Ferro, MD, Ron Ram, MD, Gabriela Rondon, MD, Richard E Champlin, MD, Brenda M. Sandmaier, MD, Kristine C. Doney, MD, Merav Bar, MD, Partow Kebriaei, MD
Journal: Blood
Blood (2013) 122 (21): 3311.
https://doi.org/10.1182/blood.V122.21.3311.3311
Published: 2013
Journal Articles

Bfr (bendamustine, fludarabine, rituximab) Nonmyeloablative Allogeneic Conditioning: A Novel Regimen Inducing Immunosuppression Without Myelosuppression

Issa F. Khouri, MD, Wei Wei, MS, Rosamar Valverde, MD, Martin Korbling, MD, Francesco Turturro, MD, Alison M Gulbis, PharmD, BCOP, Maria Guillermo-Pacheco, Sairah Ahmed, MD, Amin Alousi, MD, Betul Oran, MD, Paolo Anderlini, MD, Stefan O Ciurea, MD, Chitra M. Hosing, MD, Uday R Popat, MD, Elias Jabbour, MD, Richard E Champlin, MD, Roland Bassett
Journal: Blood
Blood (2013) 122 (21): 541.
https://doi.org/10.1182/blood.V122.21.541.541
Published: 2013
Journal Articles

Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation

Antonio Di Stasi, Michelle Poon, Amir Hamdi, Hila Shaim, Susan Xie, Denai Milton, Roland Bassett, Gabriela Rondon, Elizabeth J. Shpall, Laurence Cooper, Dean Lee, Katy Rezvani, Richard E. Champlin, Stefan O. Ciurea
Journal: Blood
Blood (2012) 120 (21): 4485.
https://doi.org/10.1182/blood.V120.21.4485.4485
Published: 2012
Journal Articles

Improved Clinical Outcomes in Chronic Lymphocytic Leukemia Patients with 17p Deletion (CLL 17p-) Who Are Able to Proceed with a Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) Following an Initial Consultation with the Transplant Service: A Single Centre Experience

LM Poon, Patricia S Fox, MS, Barry I. Samuels, MD, Susan O'Brien, M.D., Alessandra Ferrajoli, M.D., Michael J. Keating, MD, Elias J. Jabbour, MD, Yvonne Hsu, Lynne V. Abruzzo, MD, PhD, Richard E. Champlin, Roland Bassett, Issa F. Khouri, MD
Journal: Blood
Blood (2012) 120 (21): 1977.
https://doi.org/10.1182/blood.V120.21.1977.1977
Published: 2012